The University of Cincinnati Academic Health Center is a collection of health colleges and institutions of the University of Cincinnati, Cincinnati, Ohio. It trains health care professionals and provides research and patient care.

During the past decade, UC Health conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 13 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC Health" #1 sponsor was "United Therapeutics" with 4 trials, followed by "Stryker Trauma GmbH" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Bellerophon Pulse Technologies" with 2 trials sponsored and "Debiopharm International SA" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC Health" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator and "CogState Ltd." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "UC Health" are "Pulmonary Arterial Hypertension" (7 trials), "Pulmonary Hypertension" (4 trials), "Combined Pulmonary Fibrosis and Emphysema" (2 trials), "Femoral Fracture" (2 trials) and "Glioblastoma" (2 trials). Many other conditions were trialed in "UC Health" in a lesser frequency.

Most popular intervention types in "UC Health" are "Drug" (24 trials), "Device" (6 trials), "Other" (3 trials), "Combination Product" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Nivolumab" (3 trials), "Inhaled Treprostinil" (2 trials), "Ocrelizumab" (2 trials) and "AZLI" (1 trials). Other intervention names were less common.

The vast majority of trials in "UC Health" are 36 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UC Health". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in UC Health, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UC Health, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

UC Health has several departments that took part in Clinical trials: "University of Cincinnati Cancer Center-UC Medical Center" - 370 trials, "University Neurology, Inc." - 14 trials, "University of Cincinnati Addiction Sciences Division" - 5 trials, "University Dermatology Consultants" - 2 trials, "University of Cincinnati Medical Center / Investigational Pharmacy" - 2 trials, "University of Cincinnati Ohio Heart Health Center" - 2 trials